BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 25223713)

  • 1. Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea.
    Cho YY; Lim J; Oh CM; Ryu J; Jung KW; Chung JH; Won YJ; Kim SW
    Cancer; 2015 Jan; 121(2):259-68. PubMed ID: 25223713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
    J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.
    Joung JY; Lim J; Oh CM; Jung KW; Cho H; Kim SH; Seo HK; Park WS; Chung J; Lee KH; Won YJ
    PLoS One; 2015; 10(10):e0140693. PubMed ID: 26469085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
    Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB
    J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Second primary malignancy among cancer survivors - epidemiology, prognosis and clinical relevance].
    Grundmann RT; Meyer F
    Zentralbl Chir; 2012 Dec; 137(6):565-74. PubMed ID: 22426967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
    Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
    J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP; Clarke CA; Aroner S; Swetter SM
    J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program.
    Kutsenko A; Berrington de Gonzalez A; Curtis RE; Rajaraman P
    Cancer Causes Control; 2014 Jun; 25(6):659-68. PubMed ID: 24682745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second primary cancers in thyroid cancer patients: a multinational record linkage study.
    Sandeep TC; Strachan MW; Reynolds RM; Brewster DH; Scélo G; Pukkala E; Hemminki K; Anderson A; Tracey E; Friis S; McBride ML; Kee-Seng C; Pompe-Kirn V; Kliewer EV; Tonita JM; Jonasson JG; Martos C; Boffetta P; Brennan P
    J Clin Endocrinol Metab; 2006 May; 91(5):1819-25. PubMed ID: 16478820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of second primary malignancies in women with papillary thyroid cancer.
    Canchola AJ; Horn-Ross PL; Purdie DM
    Am J Epidemiol; 2006 Mar; 163(6):521-7. PubMed ID: 16421240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
    Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
    J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of developing second cancers among survivors of childhood soft tissue sarcoma.
    Cohen RJ; Curtis RE; Inskip PD; Fraumeni JF
    Cancer; 2005 Jun; 103(11):2391-6. PubMed ID: 15852362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan.
    Lee KD; Chen SC; Chan CH; Lu CH; Chen CC; Lin JT; Chen MF; Huang SH; Yeh CM; Chen MC
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2647-55. PubMed ID: 18843006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries.
    Zhu G; Chen Y; Zhu Z; Lu L; Bi X; Deng Q; Chen X; Su H; Liu Y; Guo H; Zheng T; Yu H; Zhang Y
    Dis Esophagus; 2012 Aug; 25(6):505-11. PubMed ID: 22067063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
    Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
    Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
    J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.